Terms: = Kidney tumors AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Clinical Outcome
3 results:
1. Biphasic squamoid alveolar papillary renal cell carcinoma: A unique papillary renal cell carcinoma with distinctive morphology, immunophenotype and molecular genetic features.
Li Y; Wu X; Yang J; Jiang Y; Li Y; Zhang W; Yu W
Pathol Res Pract; 2022 Nov; 239():154120. PubMed ID: 36201928
[TBL] [Abstract] [Full Text] [Related]
2. Metanephric adenoma with braf V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process.
Lenci N; Francesco P; Scarciglia E; Fiorentino V; Schino M; Palermo G; Racioppi M; Bassi P; Martini M
Med Mol Morphol; 2021 Jun; 54(2):187-191. PubMed ID: 33175195
[TBL] [Abstract] [Full Text] [Related]
3. Molecular characterisation of metanephric adenomas beyond braf: genetic evidence for potential malignant evolution.
Chan E; Stohr BA; Croom NA; Cho SJ; Garg K; Troxell ML; Higgins JP; Bean GR
Histopathology; 2020 Jun; 76(7):1084-1090. PubMed ID: 32064677
[TBL] [Abstract] [Full Text] [Related]
